GAMIFANT

This brand name is authorized in United States.

Active ingredients

The drug GAMIFANT contains one active pharmaceutical ingredient (API):

`1`	Emapalumab UNII `3S252O2Z4X` - EMAPALUMAB
	Emapalumab is a monoclonal antibody that binds to and neutralizes interferon gamma (IFNγ). Nonclinical data suggest that IFNγ plays a pivotal role in the pathogenesis of HLH by being hypersecreted.
	Read more about Emapalumab

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
GAMIFANT Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	66658-501, 66658-505, 66658-510, 72171-501, 72171-505

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.